drug-related side effects and adverse reactions

Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats
Kenji Takeda, Hiraku Ono, Ko Ishikawa, Tomohiro Ohno, Jin Kumagai, Hidetoshi Ochiai, Ai Matumoto, Hidetaka Yokoh, Yoshiro Maezawa, Koutaro Yokote

BMJ Open Diabetes Research and Care Apr 2021, 9 (1) e002104; DOI: 10.1136/bmjdrc-2020-002104
PERsistent Sitagliptin treatment & Outcomes (PERS&O 2.0) study, long-term results: a real-world observation on DPP4-inhibitor effectiveness
Antonio Carlo Bossi, Valentina De Mori, Carlotta Galeone, Davide Pietro Bertola, Margherita Gaiti, Annalisa Balini, Denise Berzi, Franco Forloni, Giancarla Meregalli, Federica Turati

BMJ Open Diabetes Research and Care Sep 2020, 8 (1) e001507; DOI: 10.1136/bmjdrc-2020-001507

Main menu